Caribou Biosciences Analyst Ratings
Citi Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Cuts Target Price to $6
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9
HC Wainwright & Co. Reiterates Buy on Caribou Biosciences, Maintains $9 Price Target
Caribou Biosciences' Strategic Advancements and Financial Efficiency Bolster Buy Rating
Evercore Maintains Caribou Biosciences(CRBU.US) With Hold Rating, Maintains Target Price $3
Truist Financial Initiates Caribou Biosciences(CRBU.US) With Buy Rating
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $9
Caribou Biosciences Analyst Ratings
Caribou Biosciences Analyst Ratings
RBC Capital Reiterates Outperform on Caribou Biosciences, Maintains $14 Price Target
Strategic Focus and Financial Runway Extension Bolster Caribou Biosciences' Buy Rating
Caribou Biosciences Analyst Ratings
Caribou Biosciences Analyst Ratings
Evercore ISI Downgrades Caribou Biosciences to In-Line Rating With $3 Price Target
Analysts Conflicted on These Healthcare Names: AstraZeneca (GB:AZN), Sartorius (GB:0NIR) and Caribou Biosciences (CRBU)
Caribou Biosciences Analyst Ratings
Truist Financial Releases a Buy Rating on Caribou Biosciences (CRBU)
Caribou Biosciences Analyst Ratings